BVMF/CVSH34 (BVMF/CVSH34)

Brazil Stock Exchange: BVMF/CVSH34 · BRL

R$48.8

-1.19 (-2.4%)· Recorded snapshot

Market cap	623.2B
Revenue (ttm)	2.1T
Net income (ttm)	25.3B
EPS (ttm)	R$2.04
P/E (trailing)	23.9x
P/E (forward)	11.1x
Dividend	R$0.91 (1.88%)
Volume	90
Beta	0.60

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.1T
Net income (ttm): 25.3B
EPS (ttm): R$2.04
P/E (trailing): 23.9x
P/E (forward): 11.1x
Market cap: 623.2B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E11.1

P25 n/aP50 n/aP75 n/a

Trailing P/E23.9

P25 n/aP50 n/aP75 n/a

ROE6.2

P25 n/aP50 n/aP75 n/a

ROIC7.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500+0.8%

Nasdaq Composite-1.0%

Dow Jones Industrial Average+1.9%

Russell 2000+0.3%

All BVMF/CVSH34 indicators

Market & fundamental data

Available fields

256

Groups with data

Currency

USD

Showing 256 of 256 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-11-04
Employees	300,000
Employees change	0
Employees growth	0%
Enterprise value	BRL 957.6B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1963
Industry	Healthcare Plans
Is primary listing	No
ISIN number	BRCVSHBDR008
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split date	2022-11-21
Last stock split type	Forward
Market cap	BRL 623.2B
Next earnings date	2026-11-04
Price	BRL 48.75
Price currency	BRL
Sector	Healthcare
SIC code	8000
Stock price date	2026-10-27
Symbol	bvmf/CVSH34
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	23.26x
Average P/E ratio (3Y)	35.75x
Average P/E ratio (5Y)	30.59x
Earnings yield	4.19%
EV/Earnings	37.8x
EV/EBIT	14.73x
EV/EBITDA	9.09x
EV/FCF	15.72x
EV/Sales	0.43x
FCF / EV yield	6.36%
FCF yield	9.77%
Forward P/E	11.12x
Graham number	37.99757
Graham upside	-22.06%
Lynch fair value	BRL 9.91
Lynch upside	-79.67%
P/(FCF - SBC) ratio	10.89x
P/(OCF - SBC) ratio	8.55x
P/B ratio	1.51x
P/E ratio	23.86x
P/FCF ratio	10.23x
P/OCF ratio	8.14x
P/S ratio	0.29x
Price/EBITDA ratio	7.21x
Sector forward P/E	11.27x
Sector P/E	41.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	2.95%
EBITDA margin	4.04%
Effective tax rate	15.59%
FCF margin	2.76%
Gross margin	13.64%
Operating margin	2.95%
Pretax margin	1.4%
Profit margin	1.19%
Profit per employee	BRL 97,627
Profitable quarters	3
Profitable years	7
Revenue per employee	BRL 8.2M
ROA	2.97%
ROA (5Y)	3.25%
ROCE	7.29%
ROE	6.21%
ROE (5Y)	7.3%
ROIC	7.17%
ROIC (5Y)	6.76%
SBC / revenue	0.17%
Tax / revenue	0.22%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	6.3%
EPS growth (Q)	188.75%
EPS growth (QoQ)	0.43%
EPS growth 10Y	-1.29%
EPS growth 3Y	18.83%
EPS growth 5Y	-6.92%
EPS growth quarters	3
EPS growth years	0
FCF growth	145.98%
FCF growth (Q)	338.3%
FCF growth (QoQ)	66.29%
FCF growth 3Y	-12.7%
FCF growth 5Y	0.24%
Gross profit growth	10.11%
Gross profit growth (Q)	15.28%
Gross profit growth 3Y	1.97%
Gross profit growth 5Y	3.1%
Net income growth	7.92%
Net income growth (Q)	191.77%
Net income growth (QoQ)	1.22%
Net income growth 3Y	18.15%
Net income growth 5Y	-7.45%
Net income growth quarters	3
Net income growth years	0
OCF growth	95.3%
OCF growth (Q)	234.48%
OCF growth (QoQ)	49.33%
OCF growth 10Y	4.54%
OCF growth 3Y	-10.36%
OCF growth 5Y	0.83%
Operating income growth	30.17%
Operating income growth (Q)	47.59%
Operating income growth 3Y	-5.64%
Operating income growth 5Y	-1.43%
Revenue growth	7.37%
Revenue growth (Q)	7.14%
Revenue growth (QoQ)	5.61%
Revenue growth 10Y	9.49%
Revenue growth 3Y	6.87%
Revenue growth 5Y	8.28%
Revenue growth quarters	53
Revenue growth years	15

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -15.7B
Depreciation and amortization	BRL 24.2B
EBIT	BRL 63B
EBITDA	BRL 86.4B
EPS	BRL 2.04
Financing cash flow	BRL -43.6B
Free cash flow	BRL 60.9B
Free cash flow minus SBC	BRL 57.2B
Gross profit	BRL 291.7B
Income taxes	BRL 4.7B
Investing cash flow	BRL -35.5B
Net borrowing	BRL -28B
Net cash flow	BRL -2.5B
Net income	BRL 25.3B
Operating cash flow minus SBC	BRL 72.9B
Operating income	BRL 63B
Revenue	BRL 2.1T
Stock-based compensation	BRL 3.7B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.43
Book value per share	BRL 323.10
Debt / EBITDA	3.87
Debt / equity	0.96
Debt / FCF	6.49
Goodwill	BRL 457.5B
Interest coverage	3.92
Long-term assets	BRL 911.4B
Long-term liabilities	BRL 434.9B
Net cash (debt)	BRL -323B
Net cash / market cap	-51.83%
Net debt / EBITDA	3.74
Net debt / equity	0.78
Net debt / FCF	5.3
Piotroski F-Score	7
Property, plant and equipment	BRL 147.8B
Shareholders' equity	BRL 413.9B
Tangible book value	BRL -157.6B
Tangible book value per share	BRL -123.32
Total assets	BRL 1.3T
Total cash	BRL 72.3B
Total debt	BRL 395.3B
Total liabilities	BRL 900.8B
WACC	5.94%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	1.61
Current assets	BRL 403.3B
Current liabilities	BRL 465.9B
Current ratio	0.87
Inventory turnover	20.32
Net working capital	BRL -112.8B
Quick ratio	0.62
Working capital	BRL -60.6B
Working capital turnover	-141.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-1.19%
Dividend growth	2.01%
Dividend growth (3Y)	3.99%
Dividend growth (5Y)	5.88%
Dividend growth years	0
Dividend payment date	2026-11-06
Dividend payment years	11
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.91
Dividend yield	1.88%
Ex-dividend date	2026-10-21
Last dividend	BRL 0.05
Payout ratio	69.86%
Shareholder yield	0.69%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	76.11%
10Y return CAGR	8.21%
10Y total return	120.04%
150-day SMA	BRL 46.46
1D price change	-2.38%
1M price change	5.43%
1M total return	5.94%
1W price change	3.88%
1W total return	4.39%
1Y price change	10.72%
1Y return CAGR	13.01%
1Y total return	13%
20-day SMA	BRL 45.90
200-day SMA	BRL 45.26
3M price change	-11.35%
3M total return	-10.91%
3Y price change	43.21%
3Y return CAGR	15.56%
3Y total return	54.35%
50-day SMA	BRL 47.12
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 58.37
52-week high date	2026-07-21
52-week low	BRL 36.78
52-week low date	2026-03-30
5Y price change	-1.3%
5Y return CAGR	1.98%
5Y total return	10.3%
6M price change	26.07%
6M total return	27.22%
All-time high	BRL 60.80
All-time high date	2022-01-06
All-time low	BRL 20.23
All-time low date	2018-04-02
Average true range (ATR)	BRL 1.20
Average volume	221
Beta (5Y)	0.6
Change from 52-week high	-16.48%
Change from 52-week low	32.55%
Change from all-time high	-19.82%
Change from all-time low	140.93%
Change from open	-1.02%
Day's gap	-1.38%
Dollar volume	BRL 4,388
High price	BRL 49.25
Low price	BRL 48.55
Monthly RSI	57.82
Open price	BRL 49.25
Position in 52-week range	28.57%
Previous close	BRL 49.94
Price vs 150-day SMA	4.93%
Price vs 20-day SMA	6.22%
Price vs 200-day SMA	7.71%
Price vs 50-day SMA	3.47%
Relative volume	0.41
RSI	58.57
Sharpe ratio	0.71
Sharpe ratio (3Y)	0.43
Sharpe ratio (5Y)	0.21
Sortino ratio	1.13
Sortino ratio (3Y)	0.74
Sortino ratio (5Y)	0.46
Volume	90
Weekly RSI	53.96
YTD price change	11.45%
YTD total return	13.75%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.3B
Shares change (QoQ)	0.63%
Shares change (YoY)	1.19%
Shares held by insiders	0.09%
Shares held by institutions	90.42%
Short ratio	2 days

Deeper analysis on BVMF/CVSH34

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this BVMF/CVSH34 report

Is a complete BVMF/CVSH34 research report available?

No complete published report is available for bvmf/CVSH34 (BVMF/CVSH34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Market cap

623.2B

Revenue (ttm)

2.1T

Net income (ttm)

25.3B

EPS (ttm)

R$2.04

P/E (trailing)

23.9x

P/E (forward)

11.1x

Dividend

R$0.91 (1.88%)

Volume

Beta

0.60

Metric

Value

Amount currency

BRL

Country

United States

Country code

Earnings date

2026-11-04

Employees

300,000

Employees change

Employees growth

Enterprise value

BRL 957.6B

Exchange

Brazil Stock Exchange

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

1963

Industry

Healthcare Plans

Is primary listing

ISIN number

BRCVSHBDR008

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split date

2022-11-21

Last stock split type

Forward

Market cap

BRL 623.2B

Next earnings date

2026-11-04

Price

BRL 48.75

Price currency

BRL

Sector

Healthcare

SIC code

8000

Stock price date

2026-10-27

Symbol

bvmf/CVSH34

Website

https://www.cvshealth.com

Metric

Value

Average P/E ratio (10Y)

23.26x

Average P/E ratio (3Y)

35.75x

Average P/E ratio (5Y)

30.59x

Earnings yield

4.19%

EV/Earnings

37.8x

EV/EBIT

14.73x

EV/EBITDA

9.09x

EV/FCF

15.72x

EV/Sales

0.43x

FCF / EV yield

6.36%

FCF yield

9.77%

Forward P/E

11.12x

Graham number

37.99757

Graham upside

-22.06%

Lynch fair value

BRL 9.91

Lynch upside

-79.67%

P/(FCF - SBC) ratio

10.89x

P/(OCF - SBC) ratio

8.55x

P/B ratio

1.51x

P/E ratio

23.86x

P/FCF ratio

10.23x

P/OCF ratio

8.14x

P/S ratio

0.29x

Price/EBITDA ratio

7.21x

Sector forward P/E

11.27x

Sector P/E

41.78x

Metric

Value

EBIT margin

2.95%

EBITDA margin

4.04%

Effective tax rate

15.59%

FCF margin

2.76%

Gross margin

13.64%

Operating margin

2.95%

Pretax margin

1.4%

Profit margin

1.19%

Profit per employee

BRL 97,627

Profitable quarters

Profitable years

Revenue per employee

BRL 8.2M

ROA

2.97%

ROA (5Y)

3.25%

ROCE

7.29%

ROE

6.21%

ROE (5Y)

7.3%

ROIC

7.17%

ROIC (5Y)

6.76%

SBC / revenue

0.17%

Tax / revenue

0.22%

Metric

Value

EPS growth

6.3%

EPS growth (Q)

188.75%

EPS growth (QoQ)

0.43%

EPS growth 10Y

-1.29%

EPS growth 3Y

18.83%

EPS growth 5Y

-6.92%

EPS growth quarters

EPS growth years

FCF growth

145.98%

FCF growth (Q)

338.3%

FCF growth (QoQ)

66.29%

FCF growth 3Y

-12.7%

FCF growth 5Y

0.24%

Gross profit growth

10.11%

Gross profit growth (Q)

15.28%

Gross profit growth 3Y

1.97%

Gross profit growth 5Y

3.1%

Net income growth

7.92%

Net income growth (Q)

191.77%

Net income growth (QoQ)

1.22%

Net income growth 3Y

18.15%

Net income growth 5Y

-7.45%

Net income growth quarters

Net income growth years

OCF growth

95.3%

OCF growth (Q)

234.48%

OCF growth (QoQ)

49.33%

OCF growth 10Y

4.54%

OCF growth 3Y

-10.36%

OCF growth 5Y

0.83%

Operating income growth

30.17%

Operating income growth (Q)

47.59%

Operating income growth 3Y

-5.64%

Operating income growth 5Y

-1.43%

Revenue growth

7.37%

Revenue growth (Q)

7.14%

Revenue growth (QoQ)

5.61%

Revenue growth 10Y

9.49%

Revenue growth 3Y

6.87%

Revenue growth 5Y

8.28%

Revenue growth quarters

Revenue growth years

Metric

Value

Capital expenditures

BRL -15.7B

Depreciation and amortization

BRL 24.2B

EBIT

BRL 63B

EBITDA

BRL 86.4B

EPS

BRL 2.04

Financing cash flow

BRL -43.6B

Free cash flow

BRL 60.9B

Free cash flow minus SBC

BRL 57.2B

Gross profit

BRL 291.7B

Income taxes

BRL 4.7B

Investing cash flow

BRL -35.5B

Net borrowing

BRL -28B

Net cash flow

BRL -2.5B

Net income

BRL 25.3B

Operating cash flow minus SBC

BRL 72.9B

Operating income

BRL 63B

Revenue

BRL 2.1T

Stock-based compensation

BRL 3.7B

Metric

Value

Altman Z-Score

2.43

Book value per share

BRL 323.10

Debt / EBITDA

3.87

Debt / equity

0.96

Debt / FCF

6.49

Goodwill

BRL 457.5B

Interest coverage

3.92

Long-term assets

BRL 911.4B

Long-term liabilities

BRL 434.9B

Net cash (debt)

BRL -323B

Net cash / market cap

-51.83%

Net debt / EBITDA

3.74

Net debt / equity

0.78

Net debt / FCF

5.3

Piotroski F-Score

Property, plant and equipment

BRL 147.8B

Shareholders' equity

BRL 413.9B

Tangible book value

BRL -157.6B

Tangible book value per share

BRL -123.32

Total assets

BRL 1.3T

Total cash

BRL 72.3B

Total debt

BRL 395.3B

Total liabilities

BRL 900.8B

WACC

5.94%

Metric

Value

Asset turnover

1.61

Current assets

BRL 403.3B

Current liabilities

BRL 465.9B

Current ratio

0.87

Inventory turnover

20.32

Net working capital

BRL -112.8B

Quick ratio

0.62

Working capital

BRL -60.6B

Working capital turnover

-141.54

Metric

Value

Buyback yield / dilution

-1.19%

Dividend growth

2.01%

Dividend growth (3Y)

3.99%

Dividend growth (5Y)

5.88%

Dividend growth years

Dividend payment date

2026-11-06

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

BRL 0.91

Dividend yield

1.88%

Ex-dividend date

2026-10-21

Last dividend

BRL 0.05

Payout ratio

69.86%

Shareholder yield

0.69%

Metric

Value

10Y price change

76.11%

10Y return CAGR

8.21%

10Y total return

120.04%

150-day SMA

BRL 46.46

1D price change

-2.38%

1M price change

5.43%

1M total return

5.94%

1W price change

3.88%

1W total return

4.39%

1Y price change

10.72%

1Y return CAGR

13.01%

1Y total return

13%

20-day SMA

BRL 45.90

200-day SMA

BRL 45.26

3M price change

-11.35%

3M total return

-10.91%

3Y price change

43.21%

3Y return CAGR

15.56%

3Y total return

54.35%

50-day SMA

BRL 47.12

50-day SMA vs 200-day SMA

50over200

52-week high

BRL 58.37

52-week high date

2026-07-21

52-week low

BRL 36.78

52-week low date

2026-03-30

5Y price change

-1.3%

5Y return CAGR

1.98%

5Y total return

10.3%

6M price change

26.07%

6M total return

27.22%

All-time high

BRL 60.80

All-time high date

2022-01-06

All-time low

BRL 20.23

All-time low date

2018-04-02

Average true range (ATR)

BRL 1.20

Average volume

221

Beta (5Y)

0.6

Change from 52-week high

-16.48%

Change from 52-week low

32.55%

Change from all-time high

-19.82%

Change from all-time low

140.93%

Change from open

-1.02%

Day's gap

-1.38%

Dollar volume

BRL 4,388

High price

BRL 49.25

Low price

BRL 48.55

Monthly RSI

57.82

Open price

BRL 49.25

Position in 52-week range

28.57%

Previous close

BRL 49.94

Price vs 150-day SMA

4.93%

Price vs 20-day SMA

6.22%

Price vs 200-day SMA

7.71%

Price vs 50-day SMA

3.47%

Relative volume

0.41

RSI

58.57

Sharpe ratio

0.71

Sharpe ratio (3Y)

0.43

Sharpe ratio (5Y)

0.21

Sortino ratio

1.13

Sortino ratio (3Y)

0.74

Sortino ratio (5Y)

0.46

Volume

Weekly RSI

53.96

YTD price change

11.45%

YTD total return

13.75%

Metric

Value

Float

1.3B

Shares change (QoQ)

0.63%

Shares change (YoY)

1.19%

Shares held by insiders

0.09%

Shares held by institutions

90.42%

Short ratio

2 days

BVMF/CVSH34 (BVMF/CVSH34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/CVSH34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/CVSH34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/CVSH34

Frequently asked questions

BVMF/CVSH34 (BVMF/CVSH34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/CVSH34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/CVSH34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/CVSH34

Frequently asked questions